A primate model for autism using the U.S. children's immunization schedule was unveiled at the International Meeting For Autism Research (IMFAR) this weekend.
The research underscores the critical need for studies into vaccine safety and the immune and mitochondrial dysfunction of autistic children. The National Autism Association (NAA) questions why the government hasn't undertaken these vital studies and why researchers have had to depend on private money to perform this critical science that will surely impact the health of millions of children worldwide.
While the authors and organizations associated with this study are withholding comment until publication, University of Pittsburgh's Dr. Laura Hewitson, Ph.D., described at the IMFAR meeting how vaccinated animals, when compared to unvaccinated animals, showed significant neurodevelopmental deficits and "significant associations between specific aberrant social and non-social behaviors, isotope binding, and vaccine exposure."
Researchers also reported at the scientific meeting that "vaccinated animals exhibited progressively severe chronic active inflammation whereas unexposed animals did not" and found "many significant differences in the GI tissue gene expression profiles between vaccinated and unvaccinated animals." Gastrointestinal issues are a common symptom of children with regressive autism.
NAA calls for the NIH to conduct large scale, non-epidemiological studies into the biomedical symptoms surrounding young children and all vaccines, including those containing the mercury-based preservative thimerosal and other additives like aluminum.